These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 37649956)

  • 1. Oral Isotretinoin and Its Uses in Dermatology: A Review.
    Paichitrojjana A; Paichitrojjana A
    Drug Des Devel Ther; 2023; 17():2573-2591. PubMed ID: 37649956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermatological indications for the use of isotretinoin beyond acne.
    Forbat E; Ali FR; Al-Niaimi F
    J Dermatolog Treat; 2018 Nov; 29(7):698-705. PubMed ID: 29480033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uses and complications of isotretinoin therapy.
    Ellis CN; Krach KJ
    J Am Acad Dermatol; 2001 Nov; 45(5):S150-7. PubMed ID: 11606947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology.
    Bagatin E; Costa CS; Rocha MADD; Picosse FR; Kamamoto CSL; Pirmez R; Ianhez M; Miot HA
    An Bras Dermatol; 2020; 95 Suppl 1(Suppl 1):19-38. PubMed ID: 33036809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders.
    Ward A; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 Jul; 28(1):6-37. PubMed ID: 6235105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose of isotretinoin: A comprehensive review.
    Abdelmaksoud A; Lotti T; Anadolu R; Goldust M; Ayhan E; Dave DD; Vestita M; Ebik B; Gupta M
    Dermatol Ther; 2020 Mar; 33(2):e13251. PubMed ID: 32022958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical isotretinoin vs. topical retinoic acid in the treatment of acne vulgaris.
    Domínguez J; Hojyo MT; Celayo JL; Domínguez-Soto L; Teixeira F
    Int J Dermatol; 1998 Jan; 37(1):54-5. PubMed ID: 9522243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of systemic retinoids in dermatology].
    Fritsch P
    Wien Klin Wochenschr; 1983 Dec; 95(23):817-22. PubMed ID: 6230801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How is oral isotretinoin prescribed for the treatment of acne vulgaris? Results from a UK Dermatology Clinical Trials Network (UKDCTN) and British Dermatological Nursing Group (BDNG) survey of health professionals.
    Moledina Z; McPhee M; Ravenscroft JC; Healy E; Radley K; Thomas KS; Burden-Teh E;
    Clin Exp Dermatol; 2023 Jan; 48(1):20-23. PubMed ID: 36669181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of isotretinoin in patients with lupus nephritis: a comprehensive review.
    Miziołek B; Bergler-Czop B; Stańkowska A; Brzezińska-Wcisło L
    Cutan Ocul Toxicol; 2017 Mar; 36(1):77-84. PubMed ID: 27160965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoids: a review.
    Dicken CH
    J Am Acad Dermatol; 1984 Oct; 11(4 Pt 1):541-52. PubMed ID: 6208221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral retinoids in the treatment of seborrhoea and acne.
    Orfanos CE; Zouboulis CC
    Dermatology; 1998; 196(1):140-7. PubMed ID: 9557249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The retinoids in acne.
    Bushnell DE; Billstein S; Schwartz RA; Lambert WC
    Am Fam Physician; 1984 Mar; 29(3):221-6. PubMed ID: 6230905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review and network meta-analysis of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris.
    Mavranezouli I; Daly CH; Welton NJ; Deshpande S; Berg L; Bromham N; Arnold S; Phillippo DM; Wilcock J; Xu J; Ravenscroft JC; Wood D; Rafiq M; Fou L; Dworzynski K; Healy E
    Br J Dermatol; 2022 Nov; 187(5):639-649. PubMed ID: 35789996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Historical aspects of the oral use of retinoids in acne.
    Hartmann D; Bollag W
    J Dermatol; 1993 Nov; 20(11):674-8. PubMed ID: 8300935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Acne Vulgaris: A Review.
    Eichenfield DZ; Sprague J; Eichenfield LF
    JAMA; 2021 Nov; 326(20):2055-2067. PubMed ID: 34812859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric disorders, acne and systemic retinoids: comparison of risks.
    Le Moigne M; Bulteau S; Grall-Bronnec M; Gerardin M; Fournier JP; Jonville-Bera AP; Jolliet P; Dreno B; Victorri-Vigneau C
    Expert Opin Drug Saf; 2017 Sep; 16(9):989-995. PubMed ID: 28657366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical retinoids in acne vulgaris: update on efficacy and safety.
    Thielitz A; Gollnick H
    Am J Clin Dermatol; 2008; 9(6):369-81. PubMed ID: 18973403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isotretinoin therapy in acne vulgaris: a 10-year retrospective study in Singapore.
    Shahidullah M; Tham SN; Goh CL
    Int J Dermatol; 1994 Jan; 33(1):60-3. PubMed ID: 8112947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roaccutane treatment guidelines: results of an international survey.
    Cunliffe WJ; van de Kerkhof PC; Caputo R; Cavicchini S; Cooper A; Fyrand OL; Gollnick H; Layton AM; Leyden JJ; Mascaró JM; Ortonne JP; Shalita A
    Dermatology; 1997; 194(4):351-7. PubMed ID: 9252756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.